MINI FUTURE SHORT - MERCK & CO. Share Price

Certificat

DE000PE618V3

Market Closed - Deutsche Boerse AG 20:50:29 10/05/2024 BST
1.68 EUR -0.59% Intraday chart for MINI FUTURE SHORT - MERCK & CO.
Current month-6.67%
1 month-16.83%
Date Price Change Volume
10/05/24 1.68 -0.59% 0
09/05/24 1.69 -2.87% 0
08/05/24 1.74 +2.35% 0
07/05/24 1.7 -13.27% 0
06/05/24 1.96 +1.03% 0

Delayed Quote Deutsche Boerse AG

Last update May 10, 2024 at 08:50 pm

More quotes

Static data

Product typeCertificat Turbo Stop Loss
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE618V
ISINDE000PE618V3
Date issued 22/12/2022
Strike 148.5 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.71
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 4.72
Lowest since issue 1.43

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1 USD
Average target price
141.6 USD
Spread / Average Target
+8.90%
Consensus